KEY FEATURES
Full Name | Tumor Necrosis Factor Receptor Superfamily, Member 1B |
---|---|
Synonym | TNFR2;CD120b;TBPII;TNF-R-II;TNF-R75;TNFBR;TNFR1B;TNFR80;p75;p75TNFR; |
Assay Type | Sandwich |
Reactivity | Human |
Range | 7.81-500pg/mL |
Sensitivity | 4.69pg/mL |
Sample Type | Serum,plasma and other biological fluids |
Sample Volume | 100μL |
Detection Wavelength | OD450 |
Transportation Temperature | 2-8°C |
Specificity | The kit detected Human TNFRSF1B in the samples and no significant cross-species reactions were found |
Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human TNFRSF1B. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human TNFRSF1B and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human TNFRSF1B, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human TNFRSF1B. You can calculate the concentration of Human TNFRSF1B in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
Components | Specifications | Storage and Notes |
---|---|---|
Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human TNFRSF1B ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
Intra-assay Precision | Inter-assay Precision | |||||
---|---|---|---|---|---|---|
Sample | 1 | 2 | 3 | 1 | 2 | 3 |
n | 20 | 20 | 20 | 20 | 20 | 20 |
Mean (pg/mL) | 25.5 | 65.67 | 237.6 | 26.51 | 67.55 | 225.04 |
Standard deviation | 1.45 | 3.67 | 8.01 | 1.62 | 3.34 | 9.88 |
CV(%) | 5.7 | 5.59 | 3.37 | 6.1 | 4.95 | 4.39 |
RECOVERY
The recovery of Human TNFRSF1B spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
Sample Type | Range (%) | Average Recovery (%) |
---|---|---|
Serum(n=8) | 92-104 | 99 |
EDTA plasma (n=8) | 85-97 | 90 |
Cell culture media (n=8) | 93-108 | 100 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human TNFRSF1B in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with TAA ELISA Kits
TNF ELISA Kit | publications with TAA and TNF |
TRAF2 ELISA Kit | publications with TAA and TRAF2 |
TRAF1 ELISA Kit | publications with TAA and TRAF1 |
TRADD ELISA Kit | publications with TAA and TRADD |
BIRC3 ELISA Kit | publications with TAA and BIRC3 |
BIRC2 ELISA Kit | publications with TAA and BIRC2 |
Pathways associated with TAA ELISA Kit
Adipocytokine Signaling Pathway | Adipocytokine Signaling Pathway |
Amyotrophic Lateral Sclerosis (ALS) Pathway | Amyotrophic Lateral Sclerosis (ALS) Pathway |
Apoptosis Pathway | Apoptosis Pathway |
Apoptosis Modulation And Signaling Pathway | Apoptosis Modulation And Signaling Pathway |
Cytokine-cytokine Receptor Interaction Pathway | Cytokine-cytokine Receptor Interaction Pathway |
IL-3 Signaling Pathway | IL-3 Signaling Pathway |
Inflammatory Response Pathway | Inflammatory Response Pathway |
Diseases associated with TAA ELISA Kit
Necrosis | publications with TAA and Necrosis |
Inflammation | publications with TAA and Inflammation |
Cardiovascular Diseases | publications with TAA and Cardiovascular Diseases |
Lung Diseases | publications with TAA and Lung Diseases |
Heart Diseases | publications with TAA and Heart Diseases |
Carcinoma | publications with TAA and Carcinoma |
Obesity | publications with TAA and Obesity |
Nervous System Diseases | publications with TAA and Nervous System Diseases |
Hypertension | publications with TAA and Hypertension |
Kidney Diseases | publications with TAA and Kidney Diseases |
Organs/Tissues associated with TAA ELISA Kit
Blood | publications with TAA and Blood |
Bone | publications with TAA and Bone |
Heart | publications with TAA and Heart |
Lung | publications with TAA and Lung |
Kidney | publications with TAA and Kidney |
Muscle | publications with TAA and Muscle |
Vascular | publications with TAA and Vascular |
Skin | publications with TAA and Skin |
Nerve | publications with TAA and Nerve |
Connective Tissue | publications with TAA and Connective Tissue |